EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Advancing Adult HPV Vaccination—Turning Evidence into Action

Meera Gosalia, Michael Moore iD, Bettina Borisch, Marta Lomazzi, The Members Of The Global Hpv Adult Vaccination Engagement Forum

Vaccines · 23.04.2026 · 14 (5) · 375

DOI: 10.3390/vaccines14050375 ↗

Kurz gefasst

Kommentar in der Zeitschrift Vaccines, online erschienen am 23.04.2026. Verfasst von Meera Gosalia und 4 weiteren Autor:innen. Beteiligte Einrichtung: World Federation of Public Health Associations (WFPHA), Institute of Global Health, University of Geneva, Campus Biotech-G6, Chemin des Mines 9, 1202…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MSD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human Papillomavirus (HPV) is one of the most prevalent infections worldwide and a leading cause of cervical cancer, as well as anal, oropharyngeal, penile, vulval, and vaginal cancers. Despite the availability of safe and effective vaccines, coverage beyond female adolescent programmes remains often insufficient, leaving many adolescents and adults unprotected. The World Federation of Public Health Associations (WFPHA) convened a year-long global expert engagement forum to develop evidence-informed policy recommendations to advance HPV elimination. Building on this work, the resulting Call-to-Action urges countries to expand access to boys and adults. Adopting a life-course approach, integrated with screening, equitable access policies, and sustainable financing, can significantly increase coverage and reduce the burden of HPV-related cancers. This article outlines the main outcomes of the Call-to-Action and highlights key priorities for policy and decision makers committed to accelerating HPV elimination.

Schlagwörter

Stichwörter der Autor:innen

HPV vaccinationcancer preventioncervical cancer eliminationglobal healthhealth equityhuman papillomavirus (HPV)public health policyuniversal vaccination

Autor:innen und Institutionen

  • World Federation of Public Health Associations (WFPHA), Institute of Global Health, University of Geneva, Campus Biotech-G6, Chemin des Mines 9, 1202 Geneva, Switzerland.
  • University College London Medical School, Gower St, London WC1E 6BT, UK.
  • Discipline of Public Helath, Health Research Institute, University of Canberra, Bruce, ACT 2617, Australia.
  • Institute of Global Health, University of Geneva, Campus Biotech-G6, Chemin des Mines 9, 1202 Geneva, Switzerland.

ORCID-Profile: Michael Moore

Förderung

  • MSD

Zitieren

APA

Gosalia, M., Moore, M., Borisch, B., Lomazzi, M., & The Members Of The Global Hpv Adult Vaccination Engagement Forum (2026). Advancing Adult HPV Vaccination—Turning Evidence into Action. Vaccines, 14(5), 375. https://doi.org/10.3390/vaccines14050375

Vancouver

Gosalia M, Moore M, Borisch B, Lomazzi M, The Members Of The Global Hpv Adult Vaccination Engagement Forum. Advancing Adult HPV Vaccination—Turning Evidence into Action. Vaccines. 2026;14(5):375. doi:10.3390/vaccines14050375

BibTeX
@article{Gosalia2026,
  author = {Gosalia, Meera and Moore, Michael and Borisch, Bettina and Lomazzi, Marta and The Members Of The Global Hpv Adult Vaccination Engagement Forum},
  title = {Advancing Adult HPV Vaccination—Turning Evidence into Action},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {375},
  doi = {10.3390/vaccines14050375}
}
Kostenlos starten →